Completed NA INTERVENTIONAL 2-arm NCT00861588

Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia

Sponsor: Chinese University of Hong Kong

Interventions isoflavones (Soylife 25) placebo

Updated 5 times since 2017 Last updated: Mar 12, 2009 Started: Feb 28, 2006 Primary completion: Sep 30, 2007 Completion: Sep 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Benign Prostate Hyperplasia and is currently completed. Chinese University of Hong Kong leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Completed NA
Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Feb 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese University of Hong Kong
School of Pharmacy, CUHK

Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong, Hong Kong